{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:18Z","timestamp":1793698038554,"version":"4.5.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673908"],"award-info":[{"award-number":["81673908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072018"],"award-info":[{"award-number":["82072018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDC07040200"],"award-info":[{"award-number":["XDC07040200"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M713055"],"award-info":[{"award-number":["2022M713055"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["BSKY 2019028"],"award-info":[{"award-number":["BSKY 2019028"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2208085QH256"],"award-info":[{"award-number":["2208085QH256"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bioadv.2023.213566","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T20:39:56Z","timestamp":1690231196000},"page":"213566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Transdermal delivery of brucine-encapsulated liposomes significantly enhances anti-tumor outcomes in treating triple-negative breast cancer"],"prefix":"10.1016","volume":"153","author":[{"given":"Min","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengpan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-1011","authenticated-orcid":false,"given":"Weiping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioadv.2023.213566_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213566_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clbc.2018.03.003","article-title":"Breast cancer and ovulation induction treatments","volume":"18","author":"Taheripanah","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213566_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-020-01259-6","article-title":"Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioadv.2023.213566_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2017.09.053","article-title":"Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigation with the anti-p53 drug, PK11007","volume":"414","author":"Synnott","year":"2018","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213566_bb0025","doi-asserted-by":"crossref","first-page":"E841","DOI":"10.1016\/j.clbc.2018.07.023","article-title":"Genetic markers in triple-negative breast cancer","volume":"18","author":"Sporikova","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"10087","key":"10.1016\/j.bioadv.2023.213566_bb0030","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213566_bb0035","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bioadv.2023.213566_bb0040","first-page":"25","article-title":"A review of systemic treatment in metastatic triple-negative breast cancer","volume":"10","author":"Zeichner","year":"2016","journal-title":"Breast Cancer (Auckl.)"},{"key":"10.1016\/j.bioadv.2023.213566_bb0045","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18888.1","article-title":"Triple-negative breast cancer: recent treatment advances","volume":"8","author":"Bergin","year":"2019","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.bioadv.2023.213566_bb0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10616-014-9723-2","article-title":"Phytochemical study, cytotoxic, analgesic, antipyretic and anti-inflammatory activities of Strychnos nux-vomica","volume":"67","author":"Eldahshan","year":"2015","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213566_bb0055","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1080\/10717544.2020.1797237","article-title":"Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles","volume":"27","author":"Elsewedy","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2023.213566_bb0060","first-page":"6543230","article-title":"Brucine suppresses vasculogenic mimicry in human triple-negative breast cancer cell line MDA-MB-231","volume":"2019","author":"Xu","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2023.213566_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jep.2018.12.045","article-title":"Brucine alleviates neuropathic pain in mice via reducing the current of the sodium channel","volume":"233","author":"Yu","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.bioadv.2023.213566_bb0070","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/j.1745-7254.2007.00654.x","article-title":"Preparation of liposomal brucine and its pharmaceutical\/pharmacodynamic characterization","volume":"28","author":"Qin","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213566_bb0075","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijms18040757","article-title":"A novel brucine gel transdermal delivery system designed for anti-inflammatory and analgesic activities","volume":"18","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2023.213566_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fphar.2020.00377","article-title":"Brucine: a review of phytochemistry, pharmacology, and toxicology","volume":"11","author":"Lu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2023.213566_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as biocompatible and smart delivery systems-the current state","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213566_bb0090","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.nano.2016.07.001","article-title":"Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles","volume":"12","author":"Bernardi","year":"2016","journal-title":"Nanomedicine"},{"issue":"33","key":"10.1016\/j.bioadv.2023.213566_bb0095","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.2174\/1381612822666160511150228","article-title":"Current status of ethosomes and elastic liposomes in dermal and transdermal drug delivery","volume":"22","author":"Ita","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2023.213566_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijpharm.2007.08.006","article-title":"Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane","volume":"349","author":"Heard","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2023.213566_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1745-6673-3-26","article-title":"Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity","volume":"3","author":"Lachenmeier","year":"2008","journal-title":"J. Occup. Med. Toxicol."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213566_bb0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioadv.2023.213566_bb0115","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S205295","article-title":"Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema","volume":"14","author":"Gao","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.bioadv.2023.213566_bb0120","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1021\/mp500277g","article-title":"Peptide-chaperone-directed transdermal protein delivery requires energy","volume":"11","author":"Ruan","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2023.213566_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.08.013","article-title":"Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin","volume":"182","author":"Zou","year":"2018","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.bioadv.2023.213566_bb0130","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/j.biomaterials.2012.08.031","article-title":"The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2023.213566_bb0135","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.2147\/IJN.S136378","article-title":"In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine","volume":"12","author":"Li","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213566_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213566_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/pharmaceutics13010123","article-title":"Quantitative Cryo-TEM reveals new structural details of Doxil-like PEGylated liposomal doxorubicin formulation","volume":"13","author":"Nordstrom","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213566_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.94","article-title":"BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton","volume":"5","author":"Maes","year":"2014","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bioadv.2023.213566_bb0155","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cells10071758","article-title":"Vasculogenic mimicry in breast cancer: clinical relevance and drivers","volume":"10","author":"Morales-Guadarrama","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bioadv.2023.213566_bb0160","first-page":"3473","article-title":"Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells","volume":"9","author":"Liu","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"9","key":"10.1016\/j.bioadv.2023.213566_bb0165","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/annonc\/mdv263","article-title":"Randomized, phase II, placebo-controlled trial of onartuzumab and\/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer","volume":"26","author":"Dieras","year":"2015","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213566_bb0170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.breast.2013.07.037","article-title":"Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer","volume":"22","author":"Curigliano","year":"2013","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213566_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-015-3482-4","article-title":"Phase I\/II trial of neoadjuvant sunitinib administered with weekly paclitaxel\/carboplatin in patients with locally advanced triple-negative breast cancer","volume":"152","author":"Yardley","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213566_bb0180","first-page":"8369","article-title":"Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213566_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15384047.2017.1294288","article-title":"Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry","volume":"18","author":"Sun","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioadv.2023.213566_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1476-4598-13-207","article-title":"Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioadv.2023.213566_bb0195","article-title":"In vitro and in vivo tumor growth inhibition by glutathione disulfide liposomes","volume":"10","author":"Sadhu","year":"2017","journal-title":"Cancer Growth Metastasis"},{"issue":"24","key":"10.1016\/j.bioadv.2023.213566_bb0200","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1039\/D1TB00126D","article-title":"Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances","volume":"9","author":"Jash","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2023.213566_bb0205","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2147\/IJN.S17255","article-title":"Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration","volume":"6","author":"Yang","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.bioadv.2023.213566_bb0210","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-02841-5","article-title":"Brucine-loaded transliposomes nanogel for topical delivery in skin cancer: statistical optimization, in vitro and dermatokinetic evaluation","volume":"11","author":"Alhakamy","year":"2021","journal-title":"3 Biotech"},{"issue":"16","key":"10.1016\/j.bioadv.2023.213566_bb0215","first-page":"3009","article-title":"In vitro transdermal permeation and penetration properties for transfersomes of brucine","volume":"41","author":"Wu","year":"2016","journal-title":"China J. Chin. Mater. Med."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213566_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11655-017-2805-1","article-title":"Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions","volume":"24","author":"Li","year":"2018","journal-title":"Chin. J. Integr. Med."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213566_bb0225","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/mp500789h","article-title":"Role of the Na+\/K+-ATPase beta-subunit in peptide-mediated transdermal drug delivery","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"issue":"16","key":"10.1016\/j.bioadv.2023.213566_bb0230","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cne.24924","article-title":"Region- and neuronal-subtype-specific expression of Na,K-ATPase alpha and beta subunit isoforms in the mouse brain","volume":"528","author":"Murata","year":"2020","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213566_bb0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","article-title":"Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application","volume":"106","author":"Jain","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213566_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11095-013-1171-8","article-title":"Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms","volume":"31","author":"Andar","year":"2014","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2023.213566_bb0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213566_bb0250","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/10717544.2017.1326539","article-title":"Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies","volume":"24","author":"Salah","year":"2017","journal-title":"Drug Deliv."}],"updated-by":[{"DOI":"10.1016\/j.bioadv.2026.215241","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000}},{"DOI":"10.1016\/j.bioadv.2026.215241","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000}}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823002893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823002893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:39:41Z","timestamp":1719873581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950823002893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"alternative-id":["S2772950823002893"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213566","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of brucine-encapsulated liposomes significantly enhances anti-tumor outcomes in treating triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"213566"}}